LifeVantage Corporation, listed on the NASDAQ:LFVN, is a key player in the health and wellness industry. The company is known for its innovative products aimed at improving health and well-being. As a publicly traded company, LifeVantage competes with other health and wellness firms, striving to maintain a strong market presence and deliver value to its shareholders.
On September 4, 2025, LifeVantage is set to release its quarterly earnings. Analysts predict an earnings per share (EPS) of $0.17, with revenue expected to reach approximately $57.9 million. This announcement will be made after the market closes, followed by a conference call for investors to discuss the results in detail.
LifeVantage's financial metrics provide insight into its market valuation. The company has a price-to-earnings (P/E) ratio of 18.31, reflecting how the market values its earnings. The price-to-sales ratio is 0.77, indicating that investors pay $0.77 for every dollar of sales. These figures help investors gauge the company's financial health and market position.
The enterprise value to sales ratio of 0.72 and the enterprise value to operating cash flow ratio of 11.97 offer further insights into LifeVantage's valuation. These ratios highlight the company's ability to generate cash flow relative to its valuation, which is crucial for assessing its financial performance and potential for growth.
LifeVantage maintains a debt-to-equity ratio of 0.36, suggesting a moderate level of debt compared to equity. The current ratio of 1.66 indicates that the company has sufficient liquidity to cover its short-term liabilities. These metrics are important for investors to consider when evaluating the company's financial stability and risk profile.
